Evolus (EOLS) Current Assets (2017 - 2026)
Evolus (EOLS) reported Current Assets of $138.9 million for Q1 2026, up 5.47% on a YoY basis from $131.7 million in Q1 2025, and down 2.79% quarter-over-quarter from $142.9 million in Q4 2025.
Evolus (EOLS) Current Assets (2017 - 2026) Analysis & Trends
Evolus has reported Current Assets for 10 years, with the latest figure at $138.9 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 5.47% year-over-year to $138.9 million; the trailing twelve-month figure through Mar 2026 stood at $138.9 million (up 5.47% YoY), and the FY2025 full-year result was $142.9 million, down 5.57% from the prior year.
- Current Assets for Q1 2026 stood at $138.9 million, down from $142.9 million in the prior quarter.
- The five-year high for Current Assets was $158.1 million in Q2 2024, with the low at $84.1 million in Q1 2023.
- Historically, Current Assets has averaged $128.4 million across 5 years, with a median of $134.9 million in 2025.
- The largest YoY upside for Current Assets was 83.91% in 2022 against a maximum downside of 43.62% in 2022.
- Evolus' Current Assets stood at $100.8 million in 2022, then rose by 11.53% to $112.4 million in 2023, then soared by 34.62% to $151.3 million in 2024, then decreased by 5.57% to $142.9 million in 2025, then declined by 2.79% to $138.9 million in 2026.
- The last three Current Assets figures came in at $138.9 million (Q1 2026), $142.9 million (Q4 2025), and $134.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 13.71 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 6.47 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 2.87 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 2.44 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 3.58 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.36 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 942.29 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.05 Bn |
| 10 | Evolus | 435.45 Mn | 385.65 Mn | 48.90 Mn | 138.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 138.92 Mn |
| Dec 31, 2025 | 142.92 Mn |
| Sep 30, 2025 | 134.89 Mn |
| Jun 30, 2025 | 144.97 Mn |
| Mar 31, 2025 | 131.72 Mn |
| Dec 31, 2024 | 151.34 Mn |
| Sep 30, 2024 | 150.36 Mn |
| Jun 30, 2024 | 158.13 Mn |
| Mar 31, 2024 | 150.27 Mn |
| Dec 31, 2023 | 112.42 Mn |
| Sep 30, 2023 | 92.00 Mn |
| Jun 30, 2023 | 96.46 Mn |
| Mar 31, 2023 | 84.09 Mn |
| Dec 31, 2022 | 100.80 Mn |
| Sep 30, 2022 | 115.95 Mn |
| Jun 30, 2022 | 133.95 Mn |
| Mar 31, 2022 | 142.93 Mn |
| Dec 31, 2021 | 178.80 Mn |
| Sep 30, 2021 | 138.34 Mn |
| Jun 30, 2021 | 161.89 Mn |